Treatment Options at Lemonaid Health Lemonaid Health offers a focused yet flexible range of medications for weight management, including both GLP-1s and more traditional alternatives
There is one GLP-1 treatment currently available in pill form, Novo Nordisks semaglutide-based drug Rybelsus, but its only approved for type 2 diabetes
(The FDA has received more than 700 adverse event reports tied to compounded GLP-1s, but its not clear if the events were caused by the drugs.) The companies also see compounders as a threat to their obesity drug sales, which are estimated to balloon to $100 billion a year by 2030
The uncomfortable part is that visual inspection catches only the obvious failures
Typical injectable GHK-Cu dose ranges Standard starting dose: 1 mg per day subcutaneous Conservative / beginner dose: 0.5 mg per day Intensive / wound-healing dose: 23 mg per day Upper research range: 4 mg per day (rarely exceeded) Frequency: once daily, or split into morning + evening microdoses for steadier levels Route: subcutaneous (SC) injection - typically abdomen , thigh or flank
& Quin, J